Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 4 days ago

      “We are pleased with the sales growth in the first three months of 2024, driven by increased demand for our GLP-1-based diabetes and obesity treatments,” Novo Nordisk CEO Lars Fruergaard Jørgensen ...